DU-41164

DU-41164 is a synthetic chemical compound that has been studied for its potential pharmacological properties. It belongs to the class of benzodiazepines, which are known for their anxiolytic, sedative, hypnotic, muscle relaxant, and anticonvulsant effects.
Chemical Structure and Properties[edit]
DU-41164 is structurally related to other benzodiazepines, featuring a core benzene ring fused to a diazepine ring. The specific molecular structure of DU-41164 includes various functional groups that contribute to its pharmacological activity. The exact chemical formula and molecular weight of DU-41164 are essential for understanding its interaction with biological systems.
Pharmacology[edit]
As a benzodiazepine, DU-41164 is believed to act on the central nervous system by enhancing the effect of the neurotransmitter gamma-aminobutyric acid (GABA) at the GABA_A receptor. This action results in increased neuronal inhibition, leading to the compound's sedative and anxiolytic effects. The pharmacokinetics of DU-41164, including its absorption, distribution, metabolism, and excretion, are crucial for determining its efficacy and safety profile.
Potential Therapeutic Uses[edit]
DU-41164 has been investigated for its potential use in treating various conditions, such as anxiety disorders, insomnia, muscle spasms, and seizure disorders. However, its clinical application requires thorough evaluation through clinical trials to establish its safety and effectiveness compared to existing treatments.
Side Effects and Risks[edit]
Like other benzodiazepines, DU-41164 may cause side effects, including drowsiness, dizziness, confusion, and dependence. Long-term use of benzodiazepines can lead to tolerance and withdrawal symptoms upon discontinuation. It is essential to monitor patients for any adverse effects and adjust the dosage accordingly.
Regulation and Legal Status[edit]
The legal status of DU-41164 varies by country, depending on its classification under national drug control laws. In some regions, it may be classified as a controlled substance due to its potential for abuse and dependence.
Research and Development[edit]
Ongoing research on DU-41164 aims to better understand its pharmacological properties and potential therapeutic applications. Studies focus on its mechanism of action, efficacy in various medical conditions, and safety profile. The development of new benzodiazepines like DU-41164 continues to be an area of interest in pharmacology and medicine.
See Also[edit]
- Benzodiazepine
- Anxiolytic
- Sedative
- Hypnotic
- Muscle relaxant
- Anticonvulsant
- GABA_A receptor
- Clinical trial
References[edit]
External Links[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian